Page last updated: 2024-08-16

temozolomide and pci 32765

temozolomide has been researched along with pci 32765 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (33.33)24.3611
2020's2 (66.67)2.80

Authors

AuthorsStudies
Bao, S; Bian, XW; Chen, C; Chen, Y; Fang, X; Feng, H; Gimple, RC; Guryanova, OA; He, Z; Huang, Z; Jiang, T; Kim, L; Kung, HF; Liu, C; Liu, Q; Ping, YF; Rich, JN; Shi, Y; Wang, W; Wang, X; Wu, J; Wu, Q; Yu, JS; Zhang, W; Zhou, W1
He, YZ; Li, X; Wang, L1
Barbieux, S; Bossard, JB; Boyle, EM; Cambier, N; Carpentier, B; Chanteau, G; Escure, G; Hieulle, J; Morschhauser, F; Renaud, L; Terriou, L; Tilmont, R; Wemeau, M1

Other Studies

3 other study(ies) available for temozolomide and pci 32765

ArticleYear
Ibrutinib inactivates BMX-STAT3 in glioma stem cells to impair malignant growth and radioresistance.
    Science translational medicine, 2018, 05-30, Volume: 10, Issue:443

    Topics: Adenine; Animals; Cell Line, Tumor; Cell Proliferation; Combined Modality Therapy; Cytokine Receptor gp130; Glioma; Janus Kinase 2; Mice; Models, Biological; Neoplastic Stem Cells; Neural Stem Cells; Piperidines; Protein Binding; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; Radiation Tolerance; STAT3 Transcription Factor; Suppressor of Cytokine Signaling 3 Protein; Survival Analysis; Temozolomide

2018
[Combination of ibrutinib and temozolomide for the treatment of newly diagnosed elderly primary central nervous system diffuse large B cell lymphoma: a case report].
    Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi, 2020, 06-14, Volume: 41, Issue:6

    Topics: Adenine; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Middle Aged; Piperidines; Positron Emission Tomography Computed Tomography; Temozolomide

2020
Treatment with temozolomide and ibrutinib in recurrent/refractory primary (PCNSL) and secondary CNS lymphoma (SCNSL).
    European journal of haematology, 2021, Volume: 107, Issue:3

    Topics: Adenine; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Central Nervous System Neoplasms; Female; Humans; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neoplasm Recurrence, Local; Neoplasms, Second Primary; Piperidines; Prognosis; Retrospective Studies; Survival Analysis; Temozolomide

2021